Reason for request
Renouvellement d'inscription
Clinical Benefit
| Substantial |
La Commission considère que le service médical rendu par CHIBROXINE, 0,3 % reste important dans les indications de l'AMM.
|
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
fFQehHC9Yvv3snuS
Listen
